Background/Aims: We aimed to evaluate the association between change in thyroid function tests within the euthyroid range and body mass index (BMI) in persons with normal weight at baseline. Methods: This study investigated 1,100 normal-weight euthyroid persons in a population-based cohort study, Tehran Thyroid Study. BMI was calculated and serum concentrations of thyrotropin (TSH) and free T4 (FT4) were assayed at baseline and after 10 years of follow-up. We evaluated the relationship between thyroid and obesity based on 2 definitions for outcome: (1) a binary outcome as BMI <25 or ≥25 kg/m2, and (2) a multinomial outcome as normal BMI, overweight, and obese. Results: A total of 569 women and 531 men, aged 36.3 ± 13.5 years, were included. Modified Poisson regression analysis for binary outcome, after adjustment for age, sex, smoking, and anti-thyroid peroxidase antibody status, revealed a negative association between delta serum FT4 and follow-up BMI (relative risk 0.55 [95% CI 0.37-0.80]) without any significant association between change in serum TSH and follow-up BMI. However, in multinomial logistic regression analysis, we found no relationship between delta serum FT4 or TSH and follow-up BMI categories, for either overweight or obese vs. normal-weight participants. Conclusions: In normal-weight euthyroid individuals, changes in serum concentrations of FT4, but not TSH, may contribute to change in body weight.

Keywords:
Thyroid, Thyrotropin, Free thyroxine, Body mass index
1.
Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW: Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009;94:1853-1878.
2.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, et al: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-781.
3.
Reinehr T: Obesity and thyroid function. Mol Cell Endocrinol 2010;316:165-171.
4.
Senese R, Lasala P, Leanza C, de Lange P: New avenues for regulation of lipid metabolism by thyroid hormones and analogs. Front Physiol 2014;5:475.
5.
de Moura Souza A, Sichieri R: Association between serum TSH concentration within the normal range and adiposity. Eur J Endocrinol 2011;165:11-15.
6.
Sakurai M, Nakamura K, Miura K, Yoshita K, Takamura T, et al: Association between a serum thyroid-stimulating hormone concentration within the normal range and indices of obesity in Japanese men and women. Intern Med 2014;53:669-674.
7.
Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, et al: Body fatness and markers of thyroid function among U.S. men and women. PLoS One 2012;7:e34979.
8.
Proces S, Delgrange E, Vander Borght TV, Jamart J, Donckier JE: Minor alterations in thyroid-function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness. Acta Clin Belg 2001;56:86-90.
9.
Ortega E, Pannacciulli N, Bogardus C, Krakoff J: Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons. Am J Clin Nutr 2007;85:440-445.
10.
Ambrosi B, Masserini B, Iorio L, Delnevo A, Malavazos AE, et al: Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects. J Endocrinol Invest 2010;33:640-643.
11.
Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, et al: Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90:4019-4024.
12.
Nyrnes A, Jorde R, Sundsfjord J: Serum TSH is positively associated with BMI. Int J Obes (Lond) 2006;30:100-105.
13.
Fox CS, Pencina MJ, DʼAgostino RB, Murabito JM, Seely EW, et al: Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 2008;168:587-592.
14.
Gopinath B, Liew G, Flood VM, Wang JJ, Kifley A, et al: The association between weight gain and thyroid function in an older population. Arch Intern Med 2008;168:2283-2284.
15.
Soriguer F, Valdes S, Morcillo S, Esteva I, Almaraz MC, et al: Thyroid hormone levels predict the change in body weight: a prospective study. Eur J Clin Invest 2011;41:1202-1209.
16.
Svare A, Nilsen TI, Bjoro T, Asvold BO, Langhammer A: Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin Endocrinol (Oxf) 2011;74:769-775.
17.
Bjergved L, Jorgensen T, Perrild H, Laurberg P, Krejbjerg A, et al: Thyroid function and body weight: a community-based longitudinal study. PLoS One 2014;9:e93515.
18.
Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y: Natural course of thyroid disease profile in a population in nutrition transition: Tehran Thyroid Study. Arch Iran Med 2013;16:418-423.
19.
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, et al: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009;10:5.
20.
Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, et al: Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Invest 2013;36:950-954.
21.
McNutt LA, Wu C, Xue X, Hafner JP: Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-943.
22.
Zou G: A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706.
23.
Greenland S: Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol 2004;160:301-305.
24.
Bastemir M, Akin F, Alkis E, Kaptanoglu B: Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007;137:431-434.
25.
De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R: Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 2007;67:265-269.
26.
Diez JJ, Iglesias P: Relationship between thyrotropin and body mass index in euthyroid subjects. Exp Clin Endocrinol Diabetes 2011;119:144-150.
27.
Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F: Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005;62:487-491.
28.
Galofre JC, Pujante P, Abreu C, Santos S, Guillen-Grima F, et al: Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 2008;53:188-194.
29.
Solanki A, Bansal S, Jindal S, Saxena V, Shukla US: Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab 2013;17(suppl 1):S167-S169.
30.
Shon HS, Jung ED, Kim SH, Lee JH: Free T4 is negatively correlated with body mass index in euthyroid women. Korean J Intern Med 2008;23:53-57.
31.
Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, et al: Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 2009;160:403-408.
32.
Shin JA, Mo EY, Kim ES, Moon SD, Han JH: Association between lower normal free thyroxine concentrations and obesity phenotype in healthy euthyroid subjects. Int J Endocrinol 2014;2014:104318.
33.
Aggarwal N, Razvi S: Thyroid and aging or the aging thyroid? An evidence-based analysis of the literature. J Thyroid Res 2013;2013:481287.
34.
De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R: Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 2007;67:265-269.
35.
Astrup A, Buemann B, Christensen NJ, Madsen J, Gluud C, et al: The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992;74:279-286.
36.
Boivin M, Camirand A, Carli F, Hoffer LJ, Silva JE: Uncoupling protein-2 and -3 messenger ribonucleic acids in adipose tissue and skeletal muscle of healthy males: variability, factors affecting expression, and relation to measures of metabolic rate. J Clin Endocrinol Metab 2000;85:1975-1983.
37.
Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH: Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007;92:491-496.
38.
Brent GA: Mechanisms of thyroid hormone action. J Clin Invest 2012;122:3035-3043.
39.
Flamant F, Samarut J: Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 2003;14:85-90.
40.
Zhang J, Lazar MA: The mechanism of action of thyroid hormones. Annu Rev Physiol 2000;62:439-466.
41.
Jansen J, Friesema EC, Milici C, Visser TJ: Thyroid hormone transporters in health and disease. Thyroid 2005;15:757-768.
42.
Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, et al: Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 2003;88:2880-2888.
43.
Hoermann R, Eckl W, Hoermann C, Larisch R: Complex relationship between free thyroxine and TSH in the regulation of thyroid function. Eur J Endocrinol 2010;162:1123-1129.
44.
Jonklaas J, Kahric-Janicic N, Soldin OP, Soldin SJ: Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin Chem 2009;55:1380-1388.
45.
Makepeace AE, Bremner AP, O'Leary P, Leedman PJ, Feddema P, et al: Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers. Clin Endocrinol (Oxf) 2008;69:648-652.
46.
Johner SA, Thamm M, Stehle P, Nöthlings U, Kriener E, et al: Interrelations between thyrotropin levels and iodine status in thyroid-healthy children. Thyroid 2014;24:1071-1079.
47.
Delshad H, Amouzegar A, Mirmiran P, Mehran L, Azizi F: Eighteen years of continuously sustained elimination of iodine deficiency in the Islamic Republic of Iran: the vitality of periodic monitoring. Thyroid 2012;22:415-421.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.